{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Open: “Nothing happened last week”… except everything\r",
      "startTime": 0,
      "endTime": 16
    },
    {
      "title": "rewind: Dr. Oz’s ‘open for business’ promise\r",
      "startTime": 16,
      "endTime": 57
    },
    {
      "title": "the ACCESS rates shocked the market (and what CMS is signaling)\r",
      "startTime": 57,
      "endTime": 103
    },
    {
      "title": "real strategy: force incumbents to adapt + invite insurgents\r",
      "startTime": 103,
      "endTime": 374
    },
    {
      "title": "anyone deliver at these prices? AI-first care & the Talkspace example\r",
      "startTime": 374,
      "endTime": 465
    },
    {
      "title": "to watch next: participants, CMS support, and ACO/PCP incentives\r",
      "startTime": 465,
      "endTime": 549
    },
    {
      "title": "earnings + the $1B Florida provider-group acquisition (CenterWell/Max)\r",
      "startTime": 549,
      "endTime": 724
    },
    {
      "title": "Humana’s deal bold or reckless? Integration risk and strategic rationale\r",
      "startTime": 724,
      "endTime": 1128
    },
    {
      "title": "narrative whiplash: WSJ vs MedPAC on Medicare Advantage costs\r",
      "startTime": 1128,
      "endTime": 1183
    },
    {
      "title": "to compare MA vs Original Medicare: selection, coding, and ‘skin substitutes’ spend\r",
      "startTime": 1183,
      "endTime": 1416
    },
    {
      "title": "consumer view: why affluent seniors still choose Original Medicare\r",
      "startTime": 1416,
      "endTime": 1465
    },
    {
      "title": "Medicare Advantage Can Be Cheaper: Premiums, Medigap & Cash-Flow Reality\r",
      "startTime": 1465,
      "endTime": 1587
    },
    {
      "title": "vs Healthcare Job Growth: The Data Doesn’t Match the Hype\r",
      "startTime": 1587,
      "endTime": 1823
    },
    {
      "title": "AI Lower Costs? ATM/Bank Teller Analogy, Jevons Paradox & More Demand\r",
      "startTime": 1823,
      "endTime": 2103
    },
    {
      "title": "Roundup: Hinge Health’s Breakout Quarter and AI-Boosted Margins\r",
      "startTime": 2103,
      "endTime": 2253
    },
    {
      "title": "Profit Machine: USPI 40% Margins, Pricing Power & Medicaid Tailwinds\r",
      "startTime": 2253,
      "endTime": 2564
    },
    {
      "title": "Earnings + ICHRA Momentum: Growth, Strategy, and the ACA Concentration Risk\r",
      "startTime": 2564,
      "endTime": 2866
    },
    {
      "title": "Next for Oscar? Medicaid/MA M&A, Corp Dev Options, and Waiting for the Dust to Settle",
      "startTime": 2866,
      "endTime": 0
    }
  ]
}